Allegis Investment Advisors’s Merck MRK Stock Holding History

Allegis Investment Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$486K	Buy	9,360 +4,790	+105%	+$259K	0.15%	140
2017 Q4	$245K	Sell	4,570 -4,792	-51%	-$266K	0.07%	194
2017 Q3	$572K	Sell	9,362 -1,184	-11%	-$71.8K	0.14%	139
2017 Q2	$645K	Buy	10,546 +1,113	+12%	+$67.8K	0.16%	133
2017 Q1	$572K	Buy	9,433 +285	+3%	+$17.3K	0.15%	140
2016 Q4	$514K	Sell	9,148 -1,092	-11%	-$63.9K	0.16%	144
2016 Q3	$610K	Sell	10,240 -488	-5%	-$28.5K	0.24%	124
2016 Q2	$584K	Sell	10,728 -1,634	-13%	-$87K	0.29%	104
2016 Q1	$624K	Buy	12,362 +621	+5%	+$30.4K	0.36%	100
2015 Q4	$592K	Buy	+11,741	New	+$592K	0.33%	87

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Allegis Investment Advisors's MRK Position: Q1 2018 in Review

Allegis Investment Advisors increased its Merck (MRK) stake by 105% in Q1 2018, buying an estimated $259K and bringing the position to 9,360 shares worth $486K. The position accounts for 0.15% of the portfolio, ranked #140.

Allegis Investment Advisors first reported a position in MRK in Q4 2015 and has held it in 10 quarters since. The position peaked at $645K in Q2 2017. 1,993 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

Allegis Investment Advisors held 9,360 shares of Merck worth $486K as of Q1 2018.
Allegis Investment Advisors bought 4,790 Merck shares in Q1 2018, an estimated $259K.
Merck made up 0.15% of Allegis Investment Advisors's portfolio in Q1 2018, its #140 holding.
Allegis Investment Advisors first reported a position in Merck in Q4 2015 and has held it in 10 quarters since.
Allegis Investment Advisors's Merck position peaked at $645K in Q2 2017.
1,993 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Allegis Investment Advisors's 13F filing for Q1 2018, filed 24 Apr 2018.